David Einhorn - DME Capital Management
Holding/activity history for Nuvation Bio Inc. (NUVB)
← All NUVB superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 34,995 | <0.01 | $4.29 | $150,129 | SEC | ||
| 2025 Q4 | 34,995 | 0.01 | $8.96 | $313,555 | SEC | ||
| 2025 Q3 | 34,995 | 0.01 | $3.70 | $129,482 | SEC | ||
| 2025 Q2 | 34,995 | <0.01 | $1.95 | $68,240 | SEC | ||
| 2025 Q1 | 34,995 | <0.01 | $1.76 | $61,591 | SEC | ||
| 2024 Q4 | 34,995 | <0.01 | $2.66 | $93,087 | SEC | ||
| 2024 Q3 | 34,995 | <0.01 | $2.29 | $80,139 | SEC | ||
| 2024 Q2 | 34,995 | <0.01 | $2.92 | $102,185 | SEC | ||
| 2024 Q1 | 34,995 | 0.01 | $3.64 | $127,382 | SEC | ||
| 2023 Q4 | 34,995 | <0.01 | $1.51 | $52,842 | SEC | ||
| 2023 Q3 | 34,995 | <0.01 | $1.34 | $46,893 | SEC | ||
| 2023 Q2 | 34,995 | <0.01 | $1.80 | $62,991 | SEC | ||
| 2023 Q1 | 34,995 | <0.01 | $1.66 | $58,092 | SEC | ||
| 2022 Q4 | 34,995 | <0.01 | $1.92 | $67,190 | SEC | ||
| 2022 Q3 | 34,995 | <0.01 | $2.23 | $78,000 | SEC | ||
| 2022 Q2 | 34,995 | <0.01 | $3.23 | $113,000 | SEC | ||
| 2022 Q1 | 34,995 | 0.01 | $5.26 | $184,000 | SEC | ||
| 2021 Q4 | 34,995 | 0.02 | $8.49 | $297,000 | SEC | ||
| 2021 Q3 | 34,995 | 0.02 | $9.94 | $348,000 | SEC | ||
| 2021 Q2 | 34,995 | 0.02 | Reduce 76.67% | 0.09 | $9.00–15.23 · VW $11.22i | $326,000 | SEC |
| 2021 Q1 | 150,000 | 0.11 | Buy | 0.11 | $8.56–15.07 · VW $12.13i | $1,568,000 | SEC |
Price snapshot:
Current price$5.77
Avg. buy price$10.45
+/- since buy-44.78%
52-week low$2.06
52-week high$9.75